IOVS Health Education Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lafuente, M. P.
Right arrow Articles by Vidal-Sanz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lafuente, M. P.
Right arrow Articles by Vidal-Sanz, M.
(Investigative Ophthalmology and Visual Science. 2001;42:2074-2084.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Neuroprotective Effects of {alpha}2-Selective Adrenergic Agonists against Ischemia-Induced Retinal Ganglion Cell Death

María P. Lafuente, María Paz Villegas-Pérez, Paloma Sobrado-Calvo, Antonio García-Avilés, Jaime Miralles de Imperial and Manuel Vidal-Sanz

From the Laboratorio de Oftalmología Experimental, Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, Spain.

PURPOSE. To investigate in adult rats the effects of two {alpha}2-selective adrenergic agonists ({alpha}2-SAs; AGN 191103 and AGN 190342) on retinal ganglion cell (RGC) survival after transient retinal ischemia.

METHODS. RGCs were labeled with a Fluorogold (FG) tracer applied to both superior colliculi. Seven days later, the left ophthalmic vessels were ligated for 60 or 90 minutes. In one group, a single dose of saline or one {alpha}2-SA was administered intraperitoneally (IP) or topically 1 hour before ischemia. In another group, a single dose of AGN 190342 was administered IP, 1, 2, 4, 24, or 72 hours after ischemia. Rats were processed 7, 14, or 21 days later. Densities of surviving RGCs were estimated by counting FG-labeled cells in 12 standard retinal areas.

RESULTS. Seven days after 60 or 90 minutes of retinal ischemia, death had occurred in 36% or 47%, respectively, of the RGC population, and by 21 days the loss of RGCs amounted to 42% or 62%, respectively. Systemic pretreatment with an {alpha}2-SA resulted in enhanced survival of ischemic-injured RGCs. Topical pretreatment with an {alpha}2-SA prevented up to 100% of the ischemia-induced RGC loss. Pretreatment with an {alpha}2-SA abolished the secondary slow RGC loss that occurred between days 7 and 21 after ischemia. When administered shortly after ischemia (up to 2 hours) AGN 190342 rescued substantial proportions of RGCs destined to die and diminished slow RGC death.

CONCLUSIONS. Pretreatment and early posttreatment with an {alpha}2-SA induces marked long-lasting neuroprotective in vivo protection against ischemia-induced cell death in RGCs.




This article has been cited by other articles:


Home page
 IOVSHome page
C.-J. Dong, Y. Guo, L. Wheeler, and W. A. Hare
{alpha}2 Adrenergic Receptor-Mediated Modulation of Cytosolic Ca++ Signals at the Inner Plexiform Layer of the Rat Retina
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1410 - 1415.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
A T Fung, S E Reid, M P Jones, P R Healey, P J McCluskey, and J C Craig
Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma
Br. J. Ophthalmol., January 1, 2007; 91(1): 62 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
F B Kalapesi, M T Coroneo, and M A Hill
Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection
Br. J. Ophthalmol., June 1, 2005; 89(6): 758 - 763.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. Wehrwein, S. A. Thompson, S. F. Coulibaly, D. M. Linn, and C. L. Linn
Acetylcholine Protection of Adult Pig Retinal Ganglion Cells from Glutamate-Induced Excitotoxicity
Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1531 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. N. Sanchez, C. K. Chan, S. Garg, J. M. K. Kwong, M. J. Wong, A. A. Sadun, and T. T. Lam
Interleukin-6 in Retinal Ischemia Reperfusion Injury in Rats
Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4006 - 4011.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Shirvan, M. Kimron, V. Holdengreber, I. Ziv, Y. Ben-Shaul, S. Melamed, E. Melamed, A. Barzilai, and A. S. Solomon
Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy
J. Biol. Chem., December 13, 2002; 277(51): 49799 - 49807.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. K. Chintala, X. Zhang, J. S. Austin, and M. E. Fini
Deficiency in Matrix Metalloproteinase Gelatinase B (MMP-9) Protects against Retinal Ganglion Cell Death after Optic Nerve Ligation
J. Biol. Chem., November 27, 2002; 277(49): 47461 - 47468.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. C. Baptiste, A. T. E. Hartwick, C. A. B. Jollimore, W. H. Baldridge, B. C. Chauhan, F. Tremblay, and M. E. M. Kelly
Comparison of the Neuroprotective Effects of Adrenoceptor Drugs in Retinal Cell Culture and Intact Retina
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2666 - 2676.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology